Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

QGEN

QIAGEN N.V.

CIK 0001015820 · NYSE

NYSEHealth CareBiological Products, (No Diagnostic Substances)
$44.07
↓ 0.83 (-1.85%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Options; Excluded: Ownership (no data)

Key stats

Market Cap
$9.10B
P/E Ratio
21.42
EPS
1.96
Dividend Yield
6.0%
52W Position
46%
Beta
0.34

Valuation multiples

Fwd P/E
13.51
PEG
1.08
P/B
2.41
P/S
4.35
EV/Revenue
4.74
ROE
11.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 46%
$32.53$57.81

Latest Financials

2025-12-31 FY
Revenue
$2.09B
Net Income
$424.88M
Total Assets
$6.28B
Free Cash Flow
$453.28M

Recent news